Effect of the proteolytic enzyme serrapeptase in patients with chronic airway disease

Respirology

Volumn 8, Issue 3, 2003, Pages 316-320

  Nakamuha, Seiichi ^a   Hashimoto, Yasushi ^a   Mikami, Masashi ^a   Yamanaka, Eiichi ^a   Soma, Tomoyijki ^b   Hino, Mitsunori ^b   Azuma, Arata ^c   Kudoh, Shoji ^c  

^a TOKYO METROPOLITAN HIROO HOSPITAL   (Japan)

^b NIPPON MEDICAL SCHOOL CHIBA HOKUSOH HOSPITAL   (Japan)

^c NIPPON MEDICAL SCHOOL   (Japan)

Author keywords

Chronic airway disease; Mucoactive; Mucociliary clearance; Serrapeptase; Sputum neutrophil; Sputum rheology; Sputum viscoelasticity

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; SERRATIOPEPTIDASE; THEOPHYLLINE;

ADULT; AGED; ARTICLE; BACTERIAL COLONIZATION; CELL COUNT; CHRONIC LUNG DISEASE; CLINICAL ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COUGHING; DISEASE ACTIVITY; DISEASE SEVERITY; FEMALE; FLOW KINETICS; HUMAN; LUNG FUNCTION; MALE; MUCOCILIARY TRANSPORT; NEUTROPHIL; PRIORITY JOURNAL; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; SPUTUM ANALYSIS; SPUTUM SMEAR; TREATMENT OUTCOME; VISCOELASTICITY; VISUAL ANALOG SCALE;

ADULT; AGED; AGED, 80 AND OVER; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BRONCHITIS, CHRONIC; ELASTICITY; FEMALE; HUMANS; LEUKOCYTE COUNT; MALE; MIDDLE AGED; NEUTROPHILS; PEPTIDE HYDROLASES; SPUTUM; TREATMENT OUTCOME; VISCOSITY;

EID: 0141513801     PISSN: 13237799     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1843.2003.00482.x     Document Type: Article

References (30)

1. Dasgupta B, King M. Molecular basis for mucolytic therapy. Can. Respir. J. 1995; 2: 223-30.
2. King M. Mucus, mucociliary clearance and coughing. In: Bates DV (ed.). Respiratory Function in Disease, 3rd edn. Saunders, Philadelphia, 1989; 69-78.
3. Annesi I, Kauffmann F. Is respiratory mucus hypersecretion really an innocent disorder? Am. Rev. Respir. Dis. 1986; 134: 688-93.
4. Sherman CB, Xu X, Speizer FE, Ferris BG Jr, Weiss ST, Dockery DW. Longitudinal lung function decline in subjects with respiratory symptoms. Am. Rev. Respir. Dis. 1992; 146: 855-9.
5. Hill SL, Burnett D, Hewetson KA, Stockley RA. The response of patients with purulent bronchiectasis to antibiotics for four months. Q. J. Med. 1988; 66: 163-73.
6. Rubin BK, Ramirez O, Zayas JG, Finegan B, King M. Collection and analysis of respiratory mucus from subjects without lung disease. Am. Rev. Respir. Dis. 1990; 141: 1040-3.
7. Wills PJ, Garcia Suarez MJ, Rutman A, Wilson R, Cole PJ. The ciliary transportability of sputum is slow on the mucus-depleted bovine trachea. Am. J. Respir. Crit. Care. Med. 1995; 151: 1255-8.
8. Lin H-C, Cheng H-F, Wang C-H, Liu C-Y, Yu C-T, Kuo H-P. Inhaled gentamicin reduces airway neutrophil activity and mucus secretion in bronchiectasis. Am. J. Respir. Crit. Care. Med. 1997; 155: 2024-9.
9. Miyata K, Hirai S, Dashiki T, Tomoda K. Intestinal absorption of serratia protease. J. Appl. Biochem. 1980; 2: 111-16.
10. Moriya N, Nakata M, Nakamura M et al. Intestinal absorption of serrapeptase (TSP) in rats. Biotechnol. Appl. Biochem. 1994; 20: 101-8.
11. Kee WH, Tan SL, Lee V, Salmon YM. The treatment of breast engorgement with Serrapeptase (Danzen): a randomized double-blind controlled trial. Singapore Med. J. 1989; 30: 48-54.
12. Esch PM, Gerngross H, Fabian A. Reduction of postoperative swelling. Objective measurement of swelling of the upper ankle joint in treatment with serrapeptase - a prospective study. Fortschr Med. 1989; 107: 67-72.
13. Mazzone A, Catalani M, Costanzo M et al. Evaluation of Serratia peptidase in acute or chronic inflammation of otorhinolaryngology pathology: a multicentre, double-blind, randomized trial versus placebo. J. Int. Med. Res. 1990; 18: 379-88.
14. Bracale G, Selvetella L. Clinical study of the efficacy of and tolerance to seaprose S in inflammatory venous disease. Controlled study versus serratio-peptidase. Minerva Cardioangiol. 1996; 44: 515-24.
15. Braga PC, Bossi R, Allegra L. Effects of serratio-peptidase on mucociliary clearance in patients with chronic bronchitis. Curr. Ther. Res. 1981; 29: 738-44.
16. Majima Y, Hirata K, Takeuchi K, Hattori M, Sakakura Y. Effects of orally administered drugs on dynamic viscoelasticity of human nasal mucus. Am. Rev. Respir. Dis. 1990; 141: 79-83.
17. Lopez-Vidriero MT, Costello J, Clark TJH, Das I, Keal EE, Reid L. Effect of atropine on sputum production. Thorax 1975; 30: 543-7.
18. Tappan V, Zalar V. The pathophysiology of bronchial mucus. Ann. NY. Acad. Sci. 1963; 106: 722-45.
19. Charman J, Lopez-Vidriero T, Keal E, Reid L. The physical and chemical properties of bronchial secretion. Br. J. Dis. Chest 1974; 68: 215-27.
20. Hayem A, Degand P. Some biological components of bronchial mucus in relation to rheological properties. Eur. J. Respir. Dis. Suppl. 1980; 110: 27-31.
21. Charman J, Reid L. The effect of freezing, storing and thawing on the viscosity of sputum. Biorheology 1973; 10: 295-301.
22. Adler K, Dulfano MJ, Wooten O. Physical properties of sputum. V. The effects of time, freezing, and thawing on viscoelasticity measurements. Am. Rev. Respir. Dis. 1974; 109: 490-3.
23. Demedts M. Assessment of airway secretions by pulmonary function tests. Eur. J. Respir. Dis. 1987; 71: 330-3.
24. Cohen AB, Rossi M. Neutrophils in normal lungs. Am. Rev. Respir. Dis. 1983; 127: s3-s9.
25. Amitani R, Wilson R, Rutman A et al. Effects of human neutrophil elastase and Pseudomonas aeruginosa proteinases on human respiratory epithelium. Am. J. Respir. Cell Mol. Biol. 1991; 4: 26-32.
26. Tegner H, Ohlsson K, Toremalm NG, von Mecklenburg C. Effect of human leukocyte enzymes on tracheal mucosa and its mucociliary activity. Rhinology 1979; 17: 199-206.
27. Sommerhoff CP, Nadel JA, Basbaum CB, Caughey GH. Neutrophil elastase and cathepsin G stimulate secretion from cultured bovine airway gland serous cells. J. Clin. Invest. 1990; 85: 682-9.
28. Chernick WS, Barbero GJ. Composition of tracheobronchial secretions in cystic fibrosis of the pancreas and bronchiectasis. Pediatrics 1959; 24: 739-45.
29. Potter J, Mathews LW, Lemm J, Spector S. The composition of pulmonary secretions from patients with and without cystic fibrosis. Am. J. Dis. Child. 1960; 100: 493-5.
30. Vasconcellos CA, Allen PG, Wohl ME, Drazen JM, Janmey PA, Stossel TP. Reduction in viscosity of cystic fibrosis sputum in vitro by gelsolin. Science 1994; 263: 969-71.